Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform
Today SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced a […]
Lantern Pharma Announces Collaboration & Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug Candidates, LP-100 and LP-184, in Solid Tumors
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform […]
Ori Biotech Raises Over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform
Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces […]
DaVita Acquires MedSleuth, Deepens Efforts to Improve Transplant Experience
DaVita Inc. today announced its acquisition of transplant software company MedSleuth. Working with transplant centers across […]
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter), a subsidiary of Abbisko Cayman Limited (Stock Code: […]
Verana Health Secures $150M Series E Funding Round
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]
HeyRenee Raises Another $4.4M in Oversubscribed Seed II Funding Round Led by Quiet Capital
HeyRenee, the newest health-tech innovation from Dr. Renee Dua and Nick Desai, the founders of […]
Ryvu Therapeutics Appoints Hendrik Nogai, M.D. as Chief Medical Officer
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule […]
Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases
Neurimmune AG today announced that it has signed an expanded drug discovery collaboration agreement with […]
Cheshire-based Life Sciences Startup Cryoniss Secures £500,000 Investment From NPIF Maven Equity Finance
NPIF Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more